---
title: "Top 10 美股漲幅（2月20日）"
description: "Ringcentral(RNG) 涨 34.4%，成交额 5.7 亿美元，年内累计涨 36.8%。 Tandem Diabetes(TNDM) 涨 32.67%，成交额 3.1 亿美元，年内累计涨 11.8%。 AXT 公司 (AXTI) 涨 24.65%，成交额 4.2 亿美元，年内累计涨 81.5%。"
type: "news"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/276490087.md"
published_at: "2026-02-20T22:01:11.000Z"
---

# Top 10 美股漲幅（2月20日）

> Ringcentral(RNG) 涨 34.4%，成交额 5.7 亿美元，年内累计涨 36.8%。 Tandem Diabetes(TNDM) 涨 32.67%，成交额 3.1 亿美元，年内累计涨 11.8%。 AXT 公司 (AXTI) 涨 24.65%，成交额 4.2 亿美元，年内累计涨 81.5%。

納斯達克綜合指數涨 0.9%，年内累計跌 1.5%；標普 500 指數涨 0.69%，年内累計涨 0.9%；道瓊斯指數涨 0.47%，年内累計涨 3.3%。

Ringcentral(RNG) 涨 34.4%，成交额 5.7 亿美元，年内累计涨 36.8%。

Tandem Diabetes(TNDM) 涨 32.67%，成交额 3.1 亿美元，年内累计涨 11.8%。

AXT 公司 (AXTI) 涨 24.65%，成交额 4.2 亿美元，年内累计涨 81.5%。

### Related Stocks

- [RNG.US - Ringcentral](https://longbridge.com/zh-HK/quote/RNG.US.md)
- [TNDM.US - Tandem Diabetes](https://longbridge.com/zh-HK/quote/TNDM.US.md)
- [AXTI.US - AXT公司](https://longbridge.com/zh-HK/quote/AXTI.US.md)
- [KOS.US - Kosmos能源](https://longbridge.com/zh-HK/quote/KOS.US.md)
- [LGN.US - Legence - CL](https://longbridge.com/zh-HK/quote/LGN.US.md)
- [SYRE.US - Spyre Therapeutics](https://longbridge.com/zh-HK/quote/SYRE.US.md)
- [FSM.US - Fortuna銀礦](https://longbridge.com/zh-HK/quote/FSM.US.md)
- [FIVN.US - Five9](https://longbridge.com/zh-HK/quote/FIVN.US.md)
- [AMN.US - AMN Healthcare Services](https://longbridge.com/zh-HK/quote/AMN.US.md)
- [VICR.US - Vicor](https://longbridge.com/zh-HK/quote/VICR.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Five9 Q4 revenue slightly beats estimates, enterprise AI revenue up 50% | Five9's Q4 revenue slightly exceeded analyst expectations, with a 50% increase in enterprise AI revenue and a record ope | [Link](https://longbridge.com/zh-HK/news/276380651.md) |
| Vicat 2025 FY EBITDA EUR 771 Million | VICAT FY EBITDA EUR 771 MILLION | [Link](https://longbridge.com/zh-HK/news/276072153.md) |
| What To Expect From AMN Healthcare Services’s (AMN) Q4 Earnings | AMN Healthcare Services will announce its Q4 earnings this Thursday. Last quarter, it beat revenue expectations by 2.7%, | [Link](https://longbridge.com/zh-HK/news/276193315.md) |
| Earnings Summary: Spyre Therapeutics Q4 | Spyre Therapeutics (NASDAQ:SYRE) reported its Q4 earnings on February 19, 2026, beating estimates by 5.41% with an EPS o | [Link](https://longbridge.com/zh-HK/news/276382581.md) |
| Tandem Diabetes Shares Rise 33% On Earnings Beat, Margin Expansion, Growth Outlook | Tandem Diabetes Care (NASDAQ:TNDM) shares surged 33% following a better-than-expected earnings report, with a smaller ad | [Link](https://longbridge.com/zh-HK/news/276472238.md) |

---

> **免責聲明**：本文內容僅供參考，不構成任何投資建議。